This topic contains a solution. Click here to go to the answer

Author Question: When interpreting factorial design data as presented on a line graph, a) main effects are ... (Read 60 times)

mrsjacobs44

  • Hero Member
  • *****
  • Posts: 500
When interpreting factorial design data as presented on a line graph,
 
  a) main effects are parallel lines and interactions are converging lines
 b) main effects are converging lines and interactions are parallel lines.
 c) both main effects and interactions are converging lines.
 d) both main effects and interactions are parallel lines.

Question 2

People in New York think the California cities of San Francisco and Los Angeles are much closer together than they actually are. This is an instance of which of the following?
 
  a) Symbolic distance effec
 b) SNARC effect
 c) Semantic congruity effect
 d) Just noticeable difference effect



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

missalyssa26

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

A

Answer to Question 2

A




mrsjacobs44

  • Member
  • Posts: 500
Reply 2 on: Jun 20, 2018
Great answer, keep it coming :)


lkanara2

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Excellent

 

Did you know?

Individuals are never “cured” of addictions. Instead, they learn how to manage their disease to lead healthy, balanced lives.

Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library